Company intelligence / Profile preview

Clearmind Medicine

Vancouver, British Columbia, Canadaclearmindmedicine.com ↗

Ownership: Public · CMND
Development stage: Phase 1

Overview

Clearmind Medicine has initiated a multi-site Phase I/IIa clinical trial of its lead candidate, CMND‑100, an oral MEAI-based drug targeting alcohol use disorder. The trial evaluates safety, tolerability, and pharmacokinetics at leading institutions including Johns Hopkins University and Yale School of Medicine. The company has also secured exclusive rights to novel psychedelic compounds for PTSD from Hebrew University. No published efficacy results yet; the company’s pipeline remains in early-stage human studies.

Therapeutic areas: Psychiatry
Modalities: Psychedelic-derived small molecules (notably MEAI/5-Methoxy-2-aminoindane)
Industry: Biotech

Drug pipeline

3 assets

5-methoxy-2-aminoindane

2 more assets in the full pipeline.

Request access →

Partnerships

Yissum Research Development Company of the Hebrew University of Jerusalem – exclusive global rights to novel compounds for PTSD and mental health disorders.

Financials

Market cap: $1.6M
Total revenue: $0
Enterprise value: $-11.9M

Beyond the preview

Go deeper on Clearmind Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clearmind Medicine.

Explore the full profile